EYEG 13G

Company

KIORA PHARMACEUTICALS INC

Filed

February 5, 2020

Accession Number

0001393825-20-000038

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →